In the present study, we investigated the safety of peptide vaccination with HLA-A*2402-restricted URLA10 and VEGFR1 epitope peptides in patients with advanced gastric cancer refractory to chemotherapy. This evidence concerns the gene HLA-A and gastric cancer.